The document summarizes trends in designer drugs from 2010 to 2012. It discusses synthetic cannabinoids like JWH-018, AM-2201, and UR-144, as well as "bath salts" containing substances like MDPV, mephedrone, and methylone. It provides information on the prevalence, legal status, and metabolites of these drugs. It also describes efforts by the forensic community to develop standardized methods for evaluating new analogs.
1 of 59
Downloaded 63 times
More Related Content
Trends Report on Changes in the Designer Drug Market: Spring 2012
1. NMS Labs Trends Report :
Changes in the Designer
Drug Market Spring 2012
Barr y K Logan PhD, DABFT
National Director Forensic
Ser vices
Willow Grove PA
6. Synthetic Cannabinoids - MI
They broke into the garage as the family slept and stole a credit card that
belonged to Cipriano's father from a car, reports say.
Cipriano used the card to buy Spice -- synthetic marijuana -- and smoked it,
reports say. Later that night, desperate for more money, he told a friend he
needed to smoke even more Spice so he didn't have second thoughts about
killing his family, according to the records.
11. K2/Spice
What is K2/Spice?
Synthetic chemicals that
look to the brain like
marijuana.
Sprayed onto plant
material for smoking.
Give marijuana-like high
Sold online and in head-
shops
Legal grey area
20. Chemicals - Summary
JWH-018/073 arrived early and have come and gone.
JWH-250 arrived a little later and as also cycled out.
JWH-081 was part of a second wave that has
already completed its cycle.
JWH-122 was part of the same wave but has
persisted in popularity and is part of the current scene.
AM-2201 was part of the same second wave and has gained in
popularity, probably currently the most prevalent.
JWH-022 and JWH-210 are showing signs of increasing popularity.
Recently emergent drugs are the adamantoyl (AM-1248) and
tetramethylcyclopropyl (XLR-11 and UR-144) indoles which are
ahead of the latest attempts to schedule these drug classes.
33. Designer Drugs Trends
Is It Federally Scheduled?
Is It State Scheduled? Is It a Federal Analog?
Is It a State Analog? Federal Analog Test:
Is it substantially
State Analog Test (varies): chemically similar?
Is it substantially chemically Does it have equivalent
similar? pharmacological activity?
Does it have equivalent Is it intended for human
pharmacological activity? consumption?
Is it intended for human
consumption?
34. PA State Analog Law
Pennsylvania: 35 P.S. 則780-102; Designer drug means a
substance other than a controlled substance that is intended
for human consumption and that either has a chemical
structure substantially similar to that of a controlled
substance in Schedules I, II or III of this act or that produces
an effect substantially similar to that of a controlled
substance in Schedules I, II or III.
Examples of chemical classes in which designer drugs are
found include, but are not limited to, the following:
Phenethylamines, N-substituted piperidines, morphinans,
ecgonines, quinazolinones, substituted indoles and
arylcycloalkylamines.
35. Congressional Action
H.R. 1254: Synthetic Drug Control Act of 2011
Amends the Controlled Substances Act to add as schedule I controlled
substances: (1) any material, compound, mixture, or preparation which
contains cannabimimetic agents (or the salts, isomers, or salts of isomers
thereof), including: any substance that is a cannabinoid receptor type 1
(CB1 receptor)
Specifically: CP-47,497, JWH-018, JWH-073, JWH-019, JWH-200,
JWH-250, JWH-081, JWH-122, JWH-398, AM-2201, AM-694, RCS-8,
RCS-4, JWH-203.
http://www.gpo.gov/fdsys/pkg/BILLS-112hr1254rfs/pdf/BILLS-112h
36. Congressional Action
H.R. 1254: Synthetic Drug Control Act of 2011
Amends the Controlled Substances Act to add as schedule I controlled
substances: (1) any material, compound, mixture, or preparation which
contains cannabimimetic agents (or the salts, isomers, or salts of isomers
thereof), including: any substance that is a cannabinoid receptor type 1
(CB1 receptor)
Specifically: CP-47,497, JWH-018, JWH-073, JWH-019, JWH-200,
JWH-250, JWH-081, JWH-122, JWH-398, AM-2201, AM-694, RCS-8,
RCS-4, JWH-203.
Mephedrone, MDPV, Methylone, naphyrone, flephedrone, methedrone,
BkPMMA, Ethcathinone , ethylone, butylone, metamfepramone, alpha-
PPP, MOPPP, MDPPP, alpha-PVP, MDAI, 3-fluoromethcathinone, MPBP,
2CE, 2CD, 2CC, 2CI, 2CT2, 2CT4, 2CH, 2CN, 2CP
37. Congressional Action
H.R. 1254: Synthetic Drug Control Act of 2011
Includes:
Any substance that is a cannabinoid receptor type 1 (CB1 receptor)
agonist as demonstrated by binding studies and functional assays within
any of the following structural classes:
2-(3-hydroxycyclohexyl)phenol with substitution
3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution
3-(1-naphthoyl)pyrrole by substitution ...
1-(1-naphthylmethylene)indene
3-phenylacetylindole or 3-benzoylindole by substitution
40. Forensic Community
Advisory Committee for the Evaluation of
Controlled Substance Analogs
Primary Objective: create a comprehensive, scientifically
sound method for evaluating non-controlled drugs for
analog status
Seek community consensus and peer review of our
proposed method
Advise and train laboratory, law enforcement, and legal
personnel in our scientific method
End Goal: Create consensus thereby removing the
expert v. expert scenario from the courtroom when the
opinion held by each expert is solely his own
41. Members and Actions
Currently consists of 20 chemists from federal, state, and
private labs, academia and law
Met at MAAFS (May 14th & 15th) to organize and strategize
Aggressive timeline to have a working document prepared
by AAFS in Feb 2013 (if not sooner)
Workshop scheduled at ACS Meeting, Phila. August 23rd
For More Information Contact:
Lindsay Reinhold, MFS, F-ABC
NMS Labs
215-366-1331
lindsay.reinhold@nmslabs.com
43. Synthetic Cannabinoids in Blood
Kacinko SL, Xu A, Homan JW, McMullin MM,
Warrington DM, Logan BK.
Development and Validation of a Liquid
Chromatography-Tandem Mass Spectrometry
Method for the Identification and Quantification of
JWH-018, JWH-073, JWH-019, and JWH-250 in
Human Whole Blood.
J Anal Toxicol. 2011;35(7):386-93.
Current Scope:
AM-2201, AM-694, JWH-018, JWH-019, JWH-073,
JWH-081, JWH-122, JWH-200, JWH-210, JWH-250,
RCS-4, RCS-8
51. NMS Labs SynCann I and II ELISA
NMS Labs Adopts
Synthetic Cannabinoids
ELISA
Two complementary ELISAs
developed and validated.
For Forensic Use Only.
All ELISA screens confirmed by
LCMSMS
Relative to current confirmatory
scope:
>96% Sensitivity
100% Selectivity
52. NMS Labs SynCann I and II ELISA
Over fifty known cross-reacting species
JWH 200
JWH 250
JWH 210
JWH 250 N-(4-Hydroxypentyl) met
JWH 210 N-(4-hydroxypentyl) met
JWH 250 N-(5-hydroxypentyl) met
JWH 210 N-(5-hydroxypentyl) met
JWH-018 6-hydroxyindole met
JWH 250 N-(4-Hydroxypentyl) met
JWH-018 7-hydroxyindole met
JWH 250 N-(5-hydroxypentyl) met
JWH-073 N-butanoic acid met
JWH 018 N-(5-chloropentyl) analog
RCS-8
JWH-018 4-hydroxyindole met
AM 2201
JWH-018 4-hydroxypentyl met
AM2201 N-(4-hydroxypentyl) met
JWH-018 5-hydroxyindole met
AM-2233
JWH-018 6-hydroxyindole met
AM-694
JWH-018 7-hydroxyindole m
JWH 022
JWH-018 N-(5-hydroxypentyl) met
JWH 081
JWH-018 N-pentanoic acid met
JWH 081 N-(4-hydroxypentyl) met
JWH 019
JWH 081 N-(5-hydroxypentyl) met
JWH-019 N-(5-hydroxyhexyl) met
JWH 098
JWH 073
JWH 122
JWH-073 4-hydroxyindole met
JWH 122 N-(5-hydroxypentyl) met
OTHERS
57. Designer Drug Outlook
Cannabinoids
More non-benzyl/naphthoyl indoles
Adamantoyl
Tetramethylcyclopropopyl
Halogenated derivatives
FAAH Inhibitors
More cocktails
Stimulants/Hallucinogens
Benzofurans
Aminoindanes
DMAA
Much greater diversity of compounds, but 8 account for 60% of all. Mepedrone (meoew Mieouw) the sentinel compound is only 1.5%. Mitragynine is the active component in Kratom. Also mixed with o-desmethyl tramadol.
Much greater diversity of compounds, but 8 account for 60% of all. Mepedrone (meoew Mieouw) the sentinel compound is only 1.5%.
the chemical structure of which is substantially similar to the chemical structure of a controlled substance in schedule I or II; (ii) which has a stimulant , depressant , or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II (iii) with respect to a particular person, which such person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II.
NMS Labs, United States Postal Inspection Service, Pennsylvania State Police, Marshall University, Retired DEA, NIST, Villanova University AIT Laboratories, Montgomery County (PA) District Attorney, FDA, Auburn University, Louisiana State Police, Pennsylvania State Police Washington State Patrol, Harris County (TX) Institute of Forensic Sciences
UR-144 XLR-11 JWH-022 JWH-203 AM-2233 AM-1248
The cutoff calibrator for this kit is JWH 250 N-(4-hydroxypentyl) metabolite at 5 ng/mL in phosphate buffered saline.